$0.55 -0.01 (-2.55%)

Vivakor, Inc. Common Stock (VIVK)

Vivakor, Inc. is a biotechnology company focused on developing and commercializing sustainable environmental and resource recovery solutions. The company specializes in advanced extraction and remediation technologies aimed at mining waste processing, oil and gas waste management, and other environmental applications. Vivakor aims to promote environmentally friendly practices through its innovative solutions.

🚫 Vivakor, Inc. Common Stock does not pay dividends

Company News

Vivakor Resets Record Date of Special Dividend of Adapti, Inc. Shares for September 5, 2025
GlobeNewswire Inc. • Vivakor, Inc. • August 19, 2025

Vivakor will distribute approximately 0.0079 shares of Adapti, Inc. as a special dividend to shareholders, with a current value of $0.515 million. The record date has been reset to September 5, 2025.

Vivakor secures $850,000 through loans and notes - Investing.com
Investing.com • Lina Guerrero • July 11, 2024

Vivakor, a refuse systems company, has secured $850,000 through loans and convertible promissory notes from an unaffiliated lender and its Chairman, President, and CEO's company. The company has also engaged a consulting firm for advisory and business development services.

Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
Benzinga • Avi Kapoor • March 26, 2024

Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. Stoke Therapeutics shares jumped 69.7% to $11.03 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Check-Cap Ltd. (NASDAQ: CHEK) shares gained 38.3% to $2.67 in pre-market trading. Nobul AI Corp entered into business combination agreement with Check-Cap. C3is Inc. (NASDAQ: CISS) rose 35.2% to $0.0476 in pre-market trading. C3is is expected to release its fourth quarter financial results before the opening bell on March 26, 2024. OpGen, Inc. (NASDAQ: OPGN) gained 30.4% to $0.6196 in pre-market trading after the company announced David Lazar will invest $3 million in preferred stock and take over as CEO. Mesoblast Limited (NASDAQ: MESO) gained 23.2% to $2.71 in pre-market trading. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory ...

5 Penny Stocks To Buy For Under $5 Right Now
PennyStocks • J. Samuel • August 23, 2022

5 penny stocks to buy for less than a large coffee but is the risk worth the reward? The post 5 Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.